Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results

Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the “APAD1” randomized controlled trial

(2019) Marion Carayol et al.   BMC CANCER

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review

(2019) E. Charton et al.   QUALITY OF LIFE RESEARCH

Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD

(2018) C. Bascoul-Mollevi et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

(2018) Amit M Oza et al.   LANCET ONCOLOGY

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

(2018) Andrew Bottomley et al.   Clinical Trials

A systematic review of the quality of statistical methods employed for analysing quality of life data in cancer randomised controlled trials

(2017) Jean-Francois Hamel et al.   EUROPEAN JOURNAL OF CANCER

Statistical Challenges in the Analysis of Health-Related Quality of Life in Cancer Clinical Trials

(2016) Franck Bonnetain et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards

(2016) Andrew Bottomley et al.   LANCET ONCOLOGY

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial

(2015) M. Hebbar et al.   ANNALS OF ONCOLOGY

Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma

(2015) Martin J.B. Taphoorn et al.   JOURNAL OF CLINICAL ONCOLOGY

Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial

(2015) Antoine Barbieri et al.   MEDICAL DECISION MAKING

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†

(2014) B. Chauffert et al.   ANNALS OF ONCOLOGY

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

(2014) Thierry Conroy et al.   LANCET ONCOLOGY

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

(2014) Mark R. Gilbert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

(2014) Olivier L. Chinot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adapted physical activity and diet (APAD) during adjuvant breast cancer therapy: Design and implementation of a prospective randomized controlled trial

(2013) Marion Carayol et al.   Contemporary Clinical Trials

Reporting of Patient-Reported Outcomes in Randomized Trials

(2013) Melanie Calvert et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?

(2013) Amélie Anota et al.   QUALITY OF LIFE RESEARCH

Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study

(2012) T. S. Dabakuyo et al.   QUALITY OF LIFE RESEARCH

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Health-related quality of life and cancer clinical trials

(2011) David Osoba   Therapeutic Advances in Medical Oncology

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial

(2010) David Azria et al.   LANCET ONCOLOGY